drat fink



View current page
...more recent posts

Wednesday, Feb 04, 2004

anonymosity

whoopsy. salon has a ridiculous article about anonymous blogging in which their idiot reporter who is parody impaired mischaracterizes a post from eschaton and then excises the questionable statement without giving notice. i guess salon wanted to exemplify shoddy reporting so as to prove accountability is a boon.

also, brad delong has an exchange with a washington post reporter that one would think is less than professional. but he can call him a fuck to his (virtual) face so its ok.

personally i dont understand what the problem is. didnt the effete french theorists manage to dissociate authorial intent and textual meaning? (some help here, please.) ones words are only credible if the author is opened up to personal scrutiny?

i suppose if you are maliciously attacking people its seems only fair that you should face up to the accused and that your motives are rendered transparent. but, if that fails to materialize, there is always libel. take them to court if theyre lying. remember how well it worked for richard perle and donald luskin? otherwise, credibility is in the eye of the beholder.

[link]


which ones pink?

billmon used 'kerry on' as a post header. i would support kerry if he would adopt kansas' Carry On as his campaign rally song. (do i smell a chance for pyrotechnics?) in fact, i think he should headline the Monsters of Seventies Rock Tour. styx, kansas, boston, bad company and john kerry. i hear hes a menace with a bass in hand. maybe he can do a rippin' number with springsteen or carlos santana. oye como vote for me.

[link]


Tuesday, Feb 03, 2004

loose your way

david weinberger has a political blog at corrante entitled loose democracy.

[link]


chaotic attractive (dread sighs ignite)

(n)income poops

[link]


pot parity

"A British company called GW Pharmaceuticals has developed a sublingual spray called Sativex which contains all the psychoactive chemicals in natural cannabis, and that medicine is likely to be approved in Britain for the treatment of MS within months. The rest of Europe and Canada will probably follow quickly, and it’s quite possible that the US won’t be too far behind."

[link]